Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women

Rheumatology International

Volumn 32, Issue 7, 2012, Pages 1927-1932

  Abdollahi, Alireza ^a   Morteza, Afsaneh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticardiolipin IgG; Antiphospholipid IgG; HIV infection; Thrombosis; Women

Indexed keywords

CARDIOLIPIN ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL NORMALIZED RATIO; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SEROTYPING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; SEX FACTORS; YOUNG ADULT;

EID: 84863990033     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1859-1     Document Type: Article

References (34)

1. Emery J, Pick N, Mills EJ, Cooper CL (2010) Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-Treated HIV-HCV coinfected patients. Patient Prefer Adherence 4:97-103
2. Collazos J, Asensi V, Carton JA (2007) Sex differences in the clinical, immunological and virological parameters of HIVinfected patients treated with HAART. Aids 21:835-843 (Pubitemid 46573155)
3. Kipp W, Alibhai A, Saunders LD, Senthilselvan A, Kaler A, Konde-Lule J, Okech-Ojony J, Rubaale T (2010) Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care 22:271-278
4. Hewitt RG, Parsa N, Gugino L (2001) The role of gender in HIV progression. Beta 14:13-16
5. Portales P, Clot J, Corbeau P (2001) Sex differences in HIV-1 viral load due to sex difference in CCR5 expression. Ann Intern Med 134:81-82 (Pubitemid 32037350)
6. Hewitt RG, Parsa N, Gugino L (2001) Women's health. The role of gender in HIV progression. AIDS Read 11:29-33 (Pubitemid 32102105)
7. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM (2002) Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis 35:313-322 (Pubitemid 34800281)
8. Prins M, Meyer L, Hessol NA (2005) Sex and the course of HIV infection in the pre-And highly active antiretroviral therapy eras. Aids 19:357-370 (Pubitemid 40446182)
9. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D (1998) Sex differences in HIV-1 viral load and progression to AIDS. Lancet 352: 1510-1514 (Pubitemid 28512927)
10. de Larranaga G, Bottaro E, Martinuzzo M, Figueroa R, Iglesias Varela ML, Peres Wingeyer S, Forastiero R, Adamczuk Y, Corti M, Puga L, Benetucci J (2009) Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study. Clin Appl Thromb Hemost 15:340-347
11. Lijfering WM, Ten Kate MK, Sprenger HG, van der Meer J (2006) Absolute risk of venous and arterial thrombosis in HIVinfected patients and effects of combination antiretroviral therapy. J Thromb Haemost 4:1928-1930 (Pubitemid 44226770)
12. Dillmon MS, Saag MS, Hamza SH, Adler BK, Marques MB (2005) Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: Case reports and review of the literature. AIDS Res Hum Retroviruses 21:753-756 (Pubitemid 41434179)
13. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM (1999) Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: Comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun 13:347-355
14. Gonzalez Dominguez J, Ortega C, Jurado R, Munoz ML, Torre-Cisneros J, Kindelan JM, Santamaria M (1995) Anticardiolipin antibodies in parenteral drug addicts: Relationship with HIV. Rev Clin Esp 195:8-11
15. Gotoh M, Matsuda J (1995) Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of an anti-cardiolipin antibody. Am J Hematol 50: 220-222
16. Llorente MR, Carton JA, Carcaba V, Rodriguez-Pinto C, Maradona JA, Asensi V, Fernandez-Urgelles M (1994) Antiphospholipid antibodies in human immunodeficiency virus infection. Med Clin (Barc) 103:10-13
17. Lim W (2009) Antiphospholipid antibody syndrome. Hematol Am Soc Hematol Educ Program 233-239
18. Jansen JM, Lijfering WM, Sprenger HG, van der Meer J, van Pampus MG (2008) Venous thromboembolism in HIV-positive women during puerperium: A case series. Blood Coagul Fibrinolysis 19:95-97
19. Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA (2006) Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 42: 572-577 (Pubitemid 44162425)
20. Abuaf N, Laperche S, Rajoely B, Carsique R, Deschamps A, Rouquette AM, Barthet C, Khaled Z, Marbot C, Saab N, Rozen J, Girard PM, Rozenbaum W (1997) Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 77:856-861 (Pubitemid 27239104)
21. Galrao L, Brites C, Atta ML, Atta A, Lima I, Gonzalez F, Magalhaes F, Santiago M (2007) Antiphospholipid antibodies in HIV-positive patients. Clin Rheumatol 26:1825-1830 (Pubitemid 47516960)
22. Falco M, Sorrenti A, Priori R, Luan FL, Pittoni V, Agresti MG, Valesini G (1993) Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome. Ann Ital Med Int 8:171-174 (Pubitemid 23313629)
23. Hassoun A, Al-Kadhimi Z, Cervia J (2004) HIV infection and antiphospholipid antibody: Literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS 18:333-340 (Pubitemid 38821789)
24. Asherson RA, Shoenfeld Y (2003) Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 30:214-219 (Pubitemid 36152579)
25. Saif MW, Greenberg B (2001) HIV and thrombosis: A review. AIDS Patient Care STDS 15:15-24 (Pubitemid 32104583)
26. Lindstrom J, Smith KJ, Skelton HG, Redfield R, Alving BM, Wagner KF, Lupton GP (1995) Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Military Medical Consortium for the Advancement of Retroviral research (MMCARR). Int J Dermatol 34:408-415
27. Lideman LF, Denisov DA, Gibadulin RA, Denisova GF (2009) Autoimmune response in HIV-infected patients is directed against CD4 domain 4. Vopr Virusol 54:12-16
28. Lopalco L, Burastero SE (2008) HIV-1 and the self-nonself connection: How to sleep with the enemy and be much better off. AIDS Rev 10:162-171
29. Katzenstein DA, Hammer SM, Hughes MD, Gundacker H, Jackson JB, Fiscus S, Rasheed S, Elbeik T, Reichman R, Japour A, Merigan TC, Hirsch MS (1996) The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS clinical trials group study 175 virology study team. N Engl J Med 335:1091-1098 (Pubitemid 26330962)
30. Zandman-Goddard G, Shoenfeld Y (2002) HIV and autoimmunity. Autoimmun Rev 1:329-337 (Pubitemid 38340245)
31. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M (2009) Sex differences in the toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955-959
32. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. J Clin Invest 115:3265-3275 (Pubitemid 41567591)
33. Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H (2006) TLR7 ligands induce higher IFN-Alpha production in females. J Immunol 177:2088-2096 (Pubitemid 44200966)
34. Liebman HA (2008) Viral-Associated immune thrombocytopenic purpura. Hematol Am Soc Hematol Educ Program 212-218